Atlas Trials

Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer

Clinical trial NCT05041842 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05041842
Sponsor
UNICANCER
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer With a Isolated Brain Progression
Start date
2021-12-17
Primary completion
2025-04-30
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.